Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van den Akker

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Plos One|June 15, 2016
Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome PatientsAnne M L Jansen, Marije A Geilenkirchen, Tom van Wezel, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2025
Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcomaSiddh van Oost, Debora M Meijer, Zeynep B Erdem, et al.
BMJ Open|March 23, 2024
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trialJ Louise I Burggraaf-van Delft, Nienke van Rein, Remy H H Bemelmans, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Plos One|June 15, 2016
Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome PatientsAnne M L Jansen, Marije A Geilenkirchen, Tom van Wezel, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2025
Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcomaSiddh van Oost, Debora M Meijer, Zeynep B Erdem, et al.
BMJ Open|March 23, 2024
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trialJ Louise I Burggraaf-van Delft, Nienke van Rein, Remy H H Bemelmans, et al.
Pageof 10